(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Researchers at Lund University in Sweden have carried out the most detailed mapping to date of the epigenome in the cells ...

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

Researchers at Lund University in Sweden have carried out the most detailed mapping to date of the epigenome in the cells ...

Children and adolescents with type 2 diabetes had an improvement in HbA1c at 26 weeks with a once-daily oral GLP-1, according ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

You can be misdiagnosed with type 2 diabetes instead of another type of the condition. This is because some symptoms may be similar, and it may not always be clear which type of diabetes you have ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

While type 1 MIs continue to dominate, the prevalence of type 2 MIs has grown in recent years among Medicare beneficiaries, an observational study shows. The shift has implications for care, ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...